Jeff Yass’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
Other funds holding AUTL
Jeff Yass's AUTL Position: Q3 2026 in Review
Jeff Yass reduced its Autolus Therapeutics (AUTL) stake by 25% in Q3 2026, selling an estimated $85K and leaving 132,727 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #11328.
Jeff Yass first reported a position in AUTL in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.19M in Q4 2025. 90 funds tracked by Wall St. Rank hold AUTL as of Q3 2026.
- Jeff Yass held 132,727 shares of Autolus Therapeutics worth $257K as of Q3 2026.
- Jeff Yass sold 44,505 Autolus Therapeutics shares in Q3 2026, an estimated $85K.
- Autolus Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11328 holding.
- Jeff Yass first reported a position in Autolus Therapeutics in Q4 2021 and has held it in 17 quarters since.
- Jeff Yass's Autolus Therapeutics position peaked at $1.19M in Q4 2025.
- 90 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.